AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.72B
FDVAX
Price
$30.42
Change
-$0.07 (-0.23%)
Updated
Oct 17 closing price
Net Assets
1.6B
Interact to see
Advertisement

AEPCX vs FDVAX

Header iconAEPCX vs FDVAX Comparison
Open Charts AEPCX vs FDVAXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.72B
Fidelity Advisor Diversified Intl A
Price$30.42
Change-$0.07 (-0.23%)
VolumeN/A
Net Assets1.6B
AEPCX vs FDVAX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. FDVAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and FDVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. FDVAX (1.6B). FDVAX pays higher dividends than AEPCX: FDVAX (1.30) vs AEPCX (0.16). AEPCX was incepted earlier than FDVAX: AEPCX (25 years) vs FDVAX (27 years). AEPCX (1.57) is less costly to investors than FDVAX (1.12). FDVAX is a more actively managed with annual turnover of: 37.00 vs. AEPCX (35.00). FDVAX has a lower initial minimum investment than AEPCX: FDVAX (0) vs AEPCX (250). FDVAX annual gain was more profitable for investors over the last year : 10.62 vs. AEPCX (10.02). FDVAX return over 5 years is better than : 19.48 vs. AEPCX (9.92).
AEPCXFDVAXAEPCX / FDVAX
Total Expense Ratio1.571.12140%
Annual Report Gross Expense Ratio1.571.12140%
Fund Existence25 years27 years-
Gain YTD20.63122.94490%
Front LoadN/A6%-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets138B1.6B8,614%
Annual Yield % from dividends0.161.3012%
Returns for 1 year10.0210.6294%
Returns for 3 years45.8555.6782%
Returns for 5 years9.9219.4851%
Returns for 10 years36.7659.0162%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp